Anavex Life Sciences Corp. (AVXL) vs Whitehawk Therapeutics, Inc. (WHWK)

Anavex Life Sciences Corp. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Anavex Life Sciences Corp. and Whitehawk Therapeutics, Inc. are of similar size ($220.1M and $216.9M). Across the 8 metrics below, Anavex Life Sciences Corp. leads on 4 and Whitehawk Therapeutics, Inc. on 4.

Valuation

Metric AVXL WHWK Biotechnology median
P/E n/m n/m 7.88
P/S n/m 11.19 11.47
P/B 1.96 1.70 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 4.39 10.73
Earnings yield (6.30%) (29.87%) (28.84%)
Free cash flow yield (13.28%) (22.49%) (23.03%)

Profitability

Metric AVXL WHWK Biotechnology median
Gross margin — 88.72% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (12.80%) (44.98%) (57.72%)
Return on assets (11.70%) (42.60%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVXL WHWK Biotechnology median
Revenue growth (TTM) — 16.51% 5.64%
EPS growth (last fiscal year) (3.85%) 86.02% —
Revenue growth, 5-year CAGR — (13.29%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVXL WHWK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.62 17.38 4.73
Net debt to EBITDA 2.00 1.26 0.96

Dividend

Metric AVXL WHWK Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AVXL WHWK Biotechnology median
Market cap 216.91m 220.05m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack